ScoreWhy is Henan Taloph Pharmaceutical Stock Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 2.63%
- The company has been able to generate a Return on Capital Employed (avg) of 2.63% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 4.65% and Operating profit at 14.89% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 1.46% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 4.65% and Operating profit at 14.89% over the last 5 years
4
Negative results in Jun 26
- PRE-TAX PROFIT(Q) At CNY 10.03 MM has Fallen at -53.62%
- NET PROFIT(Q) At CNY 5.39 MM has Fallen at -67.52%
- INTEREST(HY) At CNY 26.24 MM has Grown at 6.02%
5
With ROE of 3.80%, it has a expensive valuation with a 2.35 Price to Book Value
- Over the past year, while the stock has generated a return of 26.28%, its profits have risen by 123.7% ; the PEG ratio of the company is 0.5
- At the current price, the company has a high dividend yield of 0.2
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Henan Taloph Pharmaceutical Stock Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Henan Taloph Pharmaceutical Stock Co., Ltd.
21.67%
1.64
49.67%
China Shanghai Composite
0.9%
0.22
14.72%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
4.65%
EBIT Growth (5y)
14.89%
EBIT to Interest (avg)
1.22
Debt to EBITDA (avg)
5.60
Net Debt to Equity (avg)
0.49
Sales to Capital Employed (avg)
0.72
Tax Ratio
14.30%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.06%
ROE (avg)
1.46%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
62
Industry P/E
Price to Book Value
2.35
EV to EBIT
37.78
EV to EBITDA
26.30
EV to Capital Employed
1.86
EV to Sales
2.63
PEG Ratio
0.50
Dividend Yield
0.21%
ROCE (Latest)
4.93%
ROE (Latest)
3.80%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 114.67 MM
-19What is not working for the Company
PRE-TAX PROFIT(Q)
At CNY 10.03 MM has Fallen at -53.62%
NET PROFIT(Q)
At CNY 5.39 MM has Fallen at -67.52%
INTEREST(HY)
At CNY 26.24 MM has Grown at 6.02%
DEBTORS TURNOVER RATIO(HY)
Lowest at 1.35 times
RAW MATERIAL COST(Y)
Grown by 9.72% (YoY
CASH AND EQV(HY)
Lowest at CNY 395.85 MM
DEBT-EQUITY RATIO
(HY)
Highest at 75.74 %
INVENTORY TURNOVER RATIO(HY)
Lowest at 2.7 times
NET SALES(Q)
Fallen at -11.69%
Here's what is working for Henan Taloph Pharmaceutical Stock Co., Ltd.
Operating Cash Flow
Highest at CNY 114.67 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Depreciation
At CNY 17.55 MM has Grown at inf%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (CNY MM)
Here's what is not working for Henan Taloph Pharmaceutical Stock Co., Ltd.
Pre-Tax Profit
At CNY 10.03 MM has Fallen at -53.62%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 5.39 MM has Fallen at -67.52%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Interest
At CNY 26.24 MM has Grown at 6.02%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Debtors Turnover Ratio
Lowest at 1.35 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Net Sales
Fallen at -11.69%
Year on Year (YoY)MOJO Watch
Near term sales trend is negative
Net Sales (CNY MM)
Cash and Eqv
Lowest at CNY 395.85 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at 75.74 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Inventory Turnover Ratio
Lowest at 2.7 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Raw Material Cost
Grown by 9.72% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
Footer loading
